|

Multiple Sclerosis Clinical Trials in Fort Worth, TX

14 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 12 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 32 mi
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Phase 213 mi
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 YearsPhase 231 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 331 mi
NARCOMS Registry: A Multiple Sclerosis Registry—31 mi
TSC Biosample Repository and Natural History Database—31 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—31 mi
Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPhase 431 mi
Study of COYA 302 for the Treatment of ALSPhase 231 mi
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current StimulationN/A37 mi
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)Phase 340 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 341 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 341 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.